- Home
- HURA vs TACT Comparison
HURA vs TACT Comparison
Compare HURA & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | TACT |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Computer peripheral equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 37.2M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | HURA | TACT |
|---|---|---|
| Price | $1.42 | $3.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $5.00 |
| AVG Volume (30 Days) | ★ 3.3M | 34.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.67 |
| Revenue Next Year | N/A | $7.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $3.22 |
| 52 Week High | $4.41 | $5.70 |
Technical Indicators
Market Signals| Indicator | HURA | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 68.39 | 39.72 |
| Support Level | $0.70 | $3.34 |
| Resistance Level | $1.55 | $3.90 |
| Average True Range (ATR) | 0.21 | 0.19 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 81.37 | 4.08 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.